Opening book details…
About this book
A Retrospective Look at the Impact of Binding Site Environment on the Optimization of TRPA1 Antagonists by Elisia Villemure, Jack A. Terrett, Robin Larouche-Gauthier, Martin Déry, Huifen Chen, Rebecca M. Reese, Shannon D. Shields, Jun Chen, Steven Magnuson & Matthew Volgraf is a book available to read on EtoBox.
- Author
- Elisia Villemure, Jack A. Terrett, Robin Larouche-Gauthier, Martin Déry, Huifen Chen, Rebecca M. Reese, Shannon D. Shields, Jun Chen, Steven Magnuson & Matthew Volgraf
- Published
- 2021
- Language
- EN
More by Elisia Villemure, Jack A. Terrett, Robin Larouche-Gauthier, Martin Déry, Huifen Chen, Rebecca M. Reese, Shannon D. Shields, Jun Chen, Steven Magnuson & Matthew Volgraf
Similar books
- Creation of Fluorescent RXR Antagonists Based on CBTF-EE and Application to a Fluorescence Polarization Binding Assay — Maho Takioku, Yuta Takamura, Michiko Fujihara, Masaki Watanabe, Shoya Yamada, Mayu Kawasaki, Sohei Ito, Shogo Nakano & Hiroki Kakuta (2021)
- Covalent Occlusion of the RORγt Ligand Binding Pocket Allows Unambiguous Targeting of an Allosteric Site — Femke A. Meijer, Maxime C. M. van den Oetelaar, Richard G. Doveston, Ella N. R. Sampers & Luc Brunsveld (2021)
- Optimization of Naphthyridones into Selective TATA-Binding Protein Associated Factor 1 (TAF1) Bromodomain Inhibitors — Michael A. Clegg, Natalie H. Theodoulou, Paul Bamborough, Chun-wa Chung, Peter D. Craggs, Emmanuel H. Demont, Laurie J. Gordon, Gemma M. Liwicki, Alex Phillipou, Nicholas C. O. Tomkinson, Rab K. Prinjha & Philip G. Humphreys (2021)
- Discovery and Optimization of 7-Alkylidenyltetrahydroindazole-Based Acylsulfonamide EP3 Antagonists — Bin Zhu, Xuqing Zhang, Lili Guo, Matthew Rankin, Ivona Bakaj, George Ho, Seunghun P. Lee, Lisa Norquay & Mark Macielag (2022)
- Trisubstituted 1,3,5-Triazines: The First Ligands of the sY12-Binding Pocket on Chemokine CXCL12 — Daniel J. Sprague, Anthony E. Getschman, Tyler G. Fenske, Brian F. Volkman & Brian C. Smith (2021)
- Discovery of a Novel Series of Pyridone-Based EP3 Antagonists for the Treatment of Type 2 Diabetes — Xuqing Zhang, Bin Zhu, Lili Guo, Ivona Bakaj, Matthew Rankin, George Ho, Jack Kauffman, Seunghun P. Lee, Lisa Norquay & Mark J. Macielag (2021)